A Narrative Review on Osteogenesis Imperfecta and Its Management

[{“box”:0,”content”:”[if 992 equals=”Open Access”]n

n

n

n

Open Access

nn

n

n[/if 992]n

n

Year : June 3, 2024 at 9:26 am | [if 1553 equals=””] Volume :02 [else] Volume :02[/if 1553] | [if 424 equals=”Regular Issue”]Issue[/if 424][if 424 equals=”Special Issue”]Special Issue[/if 424] [if 424 equals=”Conference”][/if 424] : 01 | Page : 1-10

n

n

n

n

n

n

By

n

[foreach 286]n

n

n

Asad Jamal Ansari, Guisia Khan, Kudshiya Khan

n

    n t

  • n

n

n[/foreach]

n

n[if 2099 not_equal=”Yes”]n

    [foreach 286] [if 1175 not_equal=””]n t

  1. Faculty, Researcher, Researcher Integral University, Integral University, Integral University Uttar Pradesh, Uttar Pradesh, Uttar Pradesh India, India, India
  2. n[/if 1175][/foreach]

n[/if 2099][if 2099 equals=”Yes”][/if 2099]n

n

Abstract

nOsteogenesis imperfecta (OI), sometimes referred to as brittle bone disease, is a heterogeneous illness characterized by short stature, several fractures, and distorted bones. The main contributing factor to OI is mutations in the genes needed to produce type 1 collagen. While severe OI is perinatally fatal, mild OI can occasionally not be detected until maturity. The frequency of Osteogenesis imperfecta ranges from about 1:15,000 to 1:20,000 births. Five kinds of the illness are commonly differentiated, ranging in severity from moderate (type I) to deadly (type II). Types III and IV are serious types that permit survival during the newborn period, but type V has a mild to moderate phenotype and interosseous membrane calcification. The majority of the time, mutations in the col I genes result in a decrease in the production of common type I collagen (col I) or the synthesis of uncommon collagen. Moreover, it has been shown that mutations in the genes responsible for osteoblast development, col I processing, and synthesis have occurred. The objective of this study is to review the research on the current medical treatments for osteogenesis imperfecta (OI) in patients. The treatments that are currently available aim to reduce or eliminate symptoms, prevent fractures, and build bone mass. Medications like bisphosphonates, denosumab, and teriparatide are frequently used to treat OI.

n

n

n

Keywords: Osteogenesis imperfecta, bisphosphonates, denosumab, teriparatide, physiotherapy

n[if 424 equals=”Regular Issue”][This article belongs to International Journal of Orthopedic Nursing and Practices(ijornp)]

n

[/if 424][if 424 equals=”Special Issue”][This article belongs to Special Issue under section in International Journal of Orthopedic Nursing and Practices(ijornp)][/if 424][if 424 equals=”Conference”]This article belongs to Conference [/if 424]

n

n

n

How to cite this article: Asad Jamal Ansari, Guisia Khan, Kudshiya Khan. A Narrative Review on Osteogenesis Imperfecta and Its Management. International Journal of Orthopedic Nursing and Practices. May 29, 2024; 02(01):1-10.

n

How to cite this URL: Asad Jamal Ansari, Guisia Khan, Kudshiya Khan. A Narrative Review on Osteogenesis Imperfecta and Its Management. International Journal of Orthopedic Nursing and Practices. May 29, 2024; 02(01):1-10. Available from: https://journals.stmjournals.com/ijornp/article=May 29, 2024/view=0

nn[if 992 equals=”Open Access”] Full Text PDF Download[/if 992] n[if 992 not_equal=”Open Access”]

[/if 992]n[if 992 not_equal=”Open Access”] n


nn[/if 992]nn[if 379 not_equal=””]n

Browse Figures

n

n

[foreach 379]n

n[/foreach]n

n

n

n[/if 379]n

n

References

n[if 1104 equals=””]n

nn[/if 1104][if 1104 not_equal=””]n

    [foreach 1102]n t

  1. [if 1106 equals=””], [/if 1106][if 1106 not_equal=””],[/if 1106]
  2. n[/foreach]

n[/if 1104]

nn


nn[if 1114 equals=”Yes”]n

n[/if 1114]

n

n

[if 424 not_equal=””]Regular Issue[else]Published[/if 424] Subscription Review Article

n

n

[if 2146 equals=”Yes”][/if 2146][if 2146 not_equal=”Yes”][/if 2146]n

n

n

n

n

n

n

n

n

n

n

n

n

n

n

n

n

n

n

n

n[if 1748 not_equal=””]

[else]

[/if 1748]n

n

n

Volume 02
[if 424 equals=”Regular Issue”]Issue[/if 424][if 424 equals=”Special Issue”]Special Issue[/if 424] [if 424 equals=”Conference”][/if 424] 01
Received May 10, 2024
Accepted May 22, 2024
Published May 29, 2024

n

n

n

n

n

n function myFunction2() {n var x = document.getElementById(“browsefigure”);n if (x.style.display === “block”) {n x.style.display = “none”;n }n else { x.style.display = “Block”; }n }n document.querySelector(“.prevBtn”).addEventListener(“click”, () => {n changeSlides(-1);n });n document.querySelector(“.nextBtn”).addEventListener(“click”, () => {n changeSlides(1);n });n var slideIndex = 1;n showSlides(slideIndex);n function changeSlides(n) {n showSlides((slideIndex += n));n }n function currentSlide(n) {n showSlides((slideIndex = n));n }n function showSlides(n) {n var i;n var slides = document.getElementsByClassName(“Slide”);n var dots = document.getElementsByClassName(“Navdot”);n if (n > slides.length) { slideIndex = 1; }n if (n (item.style.display = “none”));n Array.from(dots).forEach(n item => (item.className = item.className.replace(” selected”, “”))n );n slides[slideIndex – 1].style.display = “block”;n dots[slideIndex – 1].className += ” selected”;n }n”}]